Physician profile
Robert J Sullivan
NPI 1538368923
$4,685.85
in general payments reported to CMS, 2019-2025
12 companies · $291 in 2025
The $291 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $878 · 2020: $238 · 2021: $418 · 2022: $480 · 2023: $1,044 · 2024: $1,337 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,671.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,911.71 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, Rotapro |
| Abbott Laboratories | $173.15 | 2024 | Eterna, Proclaim |
| Biotronik INC. | $140.78 | 2023 | Orsiro Mission |
| Vertiflex, INC. | $119.69 | 2019 | |
| Curonix LLC | $119.21 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Si-Bone, INC. | $55.52 | 2019-2023 | |
| Spr Therapeutics, INC | $47.50 | 2019-2025 | Sprint Pns System |
| Tersera Therapeutics LLC | $31.79 | 2024 | Prialt |
| Nevro Corp. | $24.50 | 2024 | Senza |
| Medtronic USA, INC. | $24.12 | 2019 | |
| Genentech USA, INC. | $21.50 | 2025 | Xolair |
| Medtronic, INC. | $16.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.